Literature DB >> 23688759

[Acute leukemia child with ocular Kaposi's sarcoma after hematopoietic stem cell transplantation: a case report and literatures review].

Hai-xia Guo1, Ke Huang, Dun-hua Zhou, Lin Wang, Jian-hui Xiao, Wen-jun Weng, Jian-pei Fang.   

Abstract

OBJECTIVE: To summarize clinical features of eye Kaposis' sarcoma ( KS ) in leukemia child after peripheral blood stem cell transplantation (PBSCT).
METHODS: One 13 years-old child with acute lymphoblastic leukemia (ALL) and negative HIV test who developed KS restricted in right conjunctiva, cornea and sclera after successful allogeneic PBSCT was reviewed retrospectively.
RESULTS: The child suffered from T cell type ALL. He received immunosuppressive treatment after PBSCT, and had once extensive herpes zoster restricted in skin. Seven months after PBSCT, he had blurred vision with right eye and slowly neoplasm formed in cornea and conjunctiva. Pathological examination confirmed KS with changes like capillary hemangioma, atypical fusiform cell, typical immunochemistry and positive immunofluorescent result of HHV8. He received excision of lump of cornea, conjunctiva, sclera and transplantation of cornea and sclera. Antiviral therapy was given together with anti-infection, prevention of cornea rejection and biotherapy. He kept right eye and hand-move eyesight, survived without GVHD or recurrence of ALL and KS.
CONCLUSION: This was the first ocular KS case in ALL child after PBSCT, without correlation with HIV infection. Complete excision combined with biotherapy was safe and effective for single ocular lesions.

Entities:  

Mesh:

Year:  2013        PMID: 23688759     DOI: 10.3760/cma.j.issn.0253-2727.2013.05.015

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  1 in total

Review 1.  Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.

Authors:  Simone Cesaro; Gloria Tridello; Steffie van der Werf; Peter Bader; Gerard Sociè; Per Ljungman; Grant McQuaker; Stefano Giardino; Duygu Uckan-Cetinkaya; Achilles Anagnostopoulos; Hakan Ozdogu; Rik Schots; Pavel Jindra; Marco Ladetto; Wilfried Schroyens; Malgorzata Mikulska; Jan Styczynski
Journal:  Bone Marrow Transplant       Date:  2019-08-21       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.